BSE Live
Oct 01, 16:01Prev. Close
1594.95
Open Price
1606.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:59Prev. Close
1594.30
Open Price
1611.90
Bid Price (Qty.)
1636.20 (60)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | |
Total Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | |
Reserves and Surplus | 71,978.09 | 63,426.82 | 55,755.45 | 47,771.29 | 46,222.85 | |
Total Reserves and Surplus | 71,978.09 | 63,426.82 | 55,755.45 | 47,771.29 | 46,222.85 | |
Total Shareholders Funds | 72,218.02 | 63,666.75 | 55,995.38 | 48,011.22 | 46,462.78 | |
Minority Interest | 267.93 | 3,439.22 | 3,320.09 | 3,054.89 | 3,017.05 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 2.52 | 1.33 | 0.00 | 229.92 | 898.13 | |
Deferred Tax Liabilities [Net] | 192.44 | 155.06 | 31.69 | 31.86 | 44.51 | |
Other Long Term Liabilities | 760.42 | 802.23 | 1,146.52 | 902.36 | 771.51 | |
Long Term Provisions | 465.04 | 413.89 | 342.91 | 369.07 | 327.12 | |
Total Non-Current Liabilities | 1,420.42 | 1,372.51 | 1,521.12 | 1,533.21 | 2,041.27 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 1,867.11 | 2,844.36 | 6,197.88 | 700.77 | 2,444.90 | |
Trade Payables | 6,184.34 | 5,653.30 | 5,681.52 | 4,479.34 | 3,973.66 | |
Other Current Liabilities | 3,987.63 | 3,129.18 | 2,673.22 | 2,872.62 | 5,144.42 | |
Short Term Provisions | 6,155.13 | 5,357.56 | 5,354.38 | 9,147.82 | 4,582.65 | |
Total Current Liabilities | 18,194.21 | 16,984.40 | 19,907.00 | 17,200.55 | 16,145.63 | |
Total Capital And Liabilities | 92,100.58 | 85,462.88 | 80,743.59 | 69,799.87 | 67,666.73 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 10,035.94 | 10,192.32 | 10,390.38 | 10,371.38 | 10,234.99 | |
Intangible Assets | 3,610.92 | 4,420.11 | 5,317.03 | 5,538.91 | 5,030.35 | |
Capital Work-In-Progress | 1,234.34 | 1,107.73 | 963.35 | 797.51 | 936.52 | |
Fixed Assets | 20,290.82 | 19,966.31 | 20,680.57 | 17,197.09 | 16,832.17 | |
Non-Current Investments | 4,697.70 | 6,441.23 | 5,457.48 | 5,214.65 | 6,482.39 | |
Deferred Tax Assets [Net] | 4,407.55 | 4,103.65 | 3,164.24 | 2,896.72 | 3,556.44 | |
Long Term Loans And Advances | 2.79 | 0.85 | 0.61 | 0.71 | 0.71 | |
Other Non-Current Assets | 1,137.83 | 2,876.91 | 2,844.64 | 2,926.27 | 4,065.30 | |
Total Non-Current Assets | 39,476.11 | 41,987.90 | 40,860.25 | 34,784.89 | 37,224.65 | |
CURRENT ASSETS | ||||||
Current Investments | 13,656.10 | 8,584.54 | 9,372.61 | 7,633.94 | 3,130.06 | |
Inventories | 10,243.33 | 9,868.29 | 10,513.05 | 8,996.81 | 8,997.02 | |
Trade Receivables | 13,046.11 | 11,249.37 | 11,438.51 | 10,592.89 | 9,061.40 | |
Cash And Cash Equivalents | 11,331.62 | 10,520.68 | 5,770.29 | 5,033.35 | 6,445.51 | |
Short Term Loans And Advances | 48.38 | 65.02 | 41.32 | 169.97 | 56.01 | |
OtherCurrentAssets | 4,298.93 | 3,187.08 | 2,747.56 | 2,588.02 | 2,752.08 | |
Total Current Assets | 52,624.47 | 43,474.98 | 39,883.34 | 35,014.98 | 30,442.08 | |
Total Assets | 92,100.58 | 85,462.88 | 80,743.59 | 69,799.87 | 67,666.73 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 6,777.61 | 6,343.60 | 7,903.07 | 6,756.55 | 7,057.73 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 183.81 | 183.81 | 183.81 | 183.81 | 183.81 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 4,486.91 | 4,242.70 | 5,254.10 | |
Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 695.79 | 818.84 | 1,080.01 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 0.00 | 0.00 | 4,934.87 | 4,031.80 | 3,099.06 | |
Current Investments Unquoted Book Value | 0.00 | 0.00 | 4,437.74 | 3,602.14 | 31.00 |
10.09.2025
07.08.2025
04.08.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875: Prabhudas Lilladher
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend
01.02.2025
Sun Pharma Consolidated December 2024 Net Sales at Rs 13,675.46 crore, up 10.46% Y-o-Y